Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1591984

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1591984

Immunoprecipitation Market by Product (Accessories, Beads, Kits), Type (Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation), End-User - Global Forecast 2025-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Immunoprecipitation Market was valued at USD 1.36 billion in 2023, expected to reach USD 1.64 billion in 2024, and is projected to grow at a CAGR of 20.78%, to USD 5.13 billion by 2030.

Immunoprecipitation (IP) is a key technique in molecular biology used to isolate a specific antigen from a mixture, utilizing an antibody-antigen interaction. Its value lies in its ability to purify proteins or nucleic acids, making it essential for applications such as protein expression analysis, gene expression studies, and post-translational modification investigations. The procedure is pivotal across diverse sectors like pharmaceuticals and biotechnology, where it aids in drug development and diagnostic research. Market growth is fueled by increasing R&D investments, advancements in proteomics, and the rising prevalence of chronic diseases requiring nuanced molecular insights. Opportunities abound in developing automated systems and creating more efficient, high-throughput antibodies, which can expedite routine lab procedures and enhance accuracy. Companies can harness these opportunities by investing in collaborative research, focusing on personalized medicine, and targeting emerging markets with innovative, cost-effective solutions. However, the market faces limitations such as high costs associated with reagents and antibodies, a requirement for skilled personnel, and challenges in maintaining specificity and yield in complex biological samples. As the sector is highly sensitive to technical developments, innovation should focus on enhancing antibody specificity, refining purification techniques, and integrating AI and machine learning to optimize data analysis and predictive modeling. Research into non-invasive sampling techniques and novel biomarkers could also unlock new potentials. The immunoprecipitation market is competitive but ripe for exploration, with trends pointing towards integrated solutions that combine IP with complementary technologies like mass spectrometry and next-generation sequencing. Businesses should remain agile, staying abreast of technological and regulatory changes, while fostering partnerships with academic institutions and tech companies to drive groundbreaking innovations. Addressing the current gaps in automation and reproducibility will be critical for sustained growth and maintaining a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 1.36 billion
Estimated Year [2024] USD 1.64 billion
Forecast Year [2030] USD 5.13 billion
CAGR (%) 20.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoprecipitation Market

The Immunoprecipitation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing applications of immunoprecipitation testing in central nervous disorders
    • Rise in the number of life science experiments and research activities
    • Development of improved protocols for chromatin immunoprecipitation
  • Market Restraints
    • Presence of alternative technologies for protein purification
  • Market Opportunities
    • Advancements in immunoprecipitation techniques
    • Rising investments by governments and various industries
  • Market Challenges
    • Issues related to quality over research antibodies

Porter's Five Forces: A Strategic Tool for Navigating the Immunoprecipitation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoprecipitation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoprecipitation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoprecipitation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoprecipitation Market

A detailed market share analysis in the Immunoprecipitation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoprecipitation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoprecipitation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoprecipitation Market

A strategic analysis of the Immunoprecipitation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprecipitation Market, highlighting leading vendors and their innovative profiles. These include Abbkine Scientific Co., Ltd, Abcam PLC, Axil Scientific Pte Ltd., Bio-Rad Laboratories, Inc., BioLegend, Inc. by PerkinElmer Inc., Cell Signaling Technology, Inc., Creative Biomart Inc., Cytoskeleton, Inc., EpiGentek Group Inc., Geno Technology, Inc., LifeSpan BioSciences, Inc., MyJoVE Corporation, Proteintech Group, Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Immunoprecipitation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Beads, Kits, and Reagents. The Accessories is further studied across Primary Antibodies and Secondary Antibodies. The Beads is further studied across Agarose Beads, Buffers, and Magnetic Beads.
  • Based on Type, market is studied across Chromatin Immunoprecipitation, Co-Immunoprecipitation, Individual Immunoprecipitation, and RNA Immunoprecipitation.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-43676CF42C5B

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing applications of immunoprecipitation testing in central nervous disorders
      • 5.1.1.2. Rise in the number of life science experiments and research activities
      • 5.1.1.3. Development of improved protocols for chromatin immunoprecipitation
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of alternative technologies for protein purification
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in immunoprecipitation techniques
      • 5.1.3.2. Rising investments by governments and various industries
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to quality over research antibodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoprecipitation Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Primary Antibodies
    • 6.2.2. Secondary Antibodies
  • 6.3. Beads
    • 6.3.1. Agarose Beads
    • 6.3.2. Buffers
    • 6.3.3. Magnetic Beads
  • 6.4. Kits
  • 6.5. Reagents

7. Immunoprecipitation Market, by Type

  • 7.1. Introduction
  • 7.2. Chromatin Immunoprecipitation
  • 7.3. Co-Immunoprecipitation
  • 7.4. Individual Immunoprecipitation
  • 7.5. RNA Immunoprecipitation

8. Immunoprecipitation Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Immunoprecipitation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoprecipitation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoprecipitation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbkine Scientific Co., Ltd
  • 2. Abcam PLC
  • 3. Axil Scientific Pte Ltd.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. BioLegend, Inc. by PerkinElmer Inc.
  • 6. Cell Signaling Technology, Inc.
  • 7. Creative Biomart Inc.
  • 8. Cytoskeleton, Inc.
  • 9. EpiGentek Group Inc.
  • 10. Geno Technology, Inc.
  • 11. LifeSpan BioSciences, Inc.
  • 12. MyJoVE Corporation
  • 13. Proteintech Group, Inc.
  • 14. Sino Biological Inc.
  • 15. Thermo Fisher Scientific Inc.
Product Code: MRR-43676CF42C5B

LIST OF FIGURES

  • FIGURE 1. IMMUNOPRECIPITATION MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOPRECIPITATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOPRECIPITATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOPRECIPITATION MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY AGAROSE BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY MAGNETIC BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CHROMATIN IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CO-IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY INDIVIDUAL IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY RNA IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IMMUNOPRECIPITATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES IMMUNOPRECIPITATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY BEADS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM IMMUNOPRECIPITATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. IMMUNOPRECIPITATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. IMMUNOPRECIPITATION MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!